TCL Archive RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment September 27, 2013
TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive Power’s Offer to Write Report On NCAB’s Organ Systems Decision Declined By DeVita June 15, 1984
TCL Archive Funding Opportunity: Leukemia & Lymphoma Society Launches Myeloid Program October 31, 2014
